Quantification of ICOS+BATF+IL-4+ TFH cells revealed that approximately 60% of ICOS+IL-4+ TFH cells in an IgG4-RD lymph node patient expressed BATF (Fig 2I). The gene discussed is ICOS; the disease is immunoglobulin G4-related sclerosing disease.